Effectiveness of psychosocial interventions for the prevention and treatment of foot ulcers in people with diabetes: a systematic review by Norman, Gill et al.
Systematic Review Or Meta-Analysis
Effectiveness of psychosocial interventions for the
prevention and treatment of foot ulcers in people with
diabetes: a systematic review
G. Norman1 , M. J. Westby2 , K. Vedhara3 , F. Game4 and N. A. Cullum1,5
1Division of Nursing, Midwifery and Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester,
2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, 3Division of Primary Care, Faculty of Medicine
and Health Sciences, University of Nottingham, Nottingham, 4Department of Diabetes and Endocrinology, University Hospitals of Derby and Burton NHS
Foundation Trust, Derby and 5Manchester Academic Health Science Centre, Research and Innovation Division, Manchester University Foundation NHS Trust,
Manchester, UK
Accepted 14 May 2020
Abstract
Aim To identify and synthesize the evidence for the effectiveness of psychosocial interventions to promote the healing,
and/or reduce the occurrence of, foot ulceration in people with diabetes.
Methods In March 2019 we searched CENTRAL, Medline, Embase and PsycInfo for randomized controlled trials of
interventions with psychosocial components for people with diabetes. The primary outcomes of this review were foot
ulceration and healing. We assessed studies using the Cochrane risk-of-bias tool, the TIDieR checklist and GRADE. We
conducted narrative synthesis and random-effects meta-analysis.
Results We included 31 randomized controlled trials (4511 participants), of which most (24 randomized controlled
trials, 4093 participants) were prevention studies. Most interventions were educational with a modest psychosocial
component. Ulceration and healing were not reported in most studies; secondary outcomes varied. Evidence was of low
or very low quality because of high risks of bias and imprecision, and few studies reported adherence or fidelity. In
groups where participants had prior ulceration, educational interventions had no clear effect on new ulceration (low-
quality evidence). Two treatment studies, assessing continuous pharmacist support and an intervention to promote
understanding of well-being, reported healing but their evidence was also of very low quality.
Conclusion Most psychosocial intervention randomized controlled trials assessing foot ulcer outcomes in people with
diabetes were prevention studies, and most interventions were primarily educational. Ulcer healing and development
were not well reported. There is a need for better understanding of psychological and behavioural influences on ulcer
incidence, healing and recurrence in people with diabetes. Randomized controlled trials of theoretically informed
interventions, which assess clinical outcomes, are urgently required. (PROSPERO registration: CRD42016052960).
Diabet. Med. 00, 1–10 (2020)
Introduction
Diabetes mellitus is an increasingly common condition that is
expected to affect more than 578 million people globally by
2030 [1]. Success in treating diabetes has improved the life
expectancy of those affected; however, increased prevalence,
coupled with the extended time people live with diabetes, has
led to increased numbers of diabetes-related complications,
including foot ulceration (defined as a wound that extends
through the full thickness of the skin below the level of the
ankle, irrespective of duration) [2]. Foot ulceration is reported
to affect 15–25% of people with diabetes at some time in their
lives and people with both type 1 and type 2 diabetes are
affected [3–5]. UK surveys estimate that approximately 1–4%
of peoplewith diabetes have foot ulcers at any given time [6,7];
a 2008 US prevalence estimate was 8% amongst people with
diabetes receiving Medicare [8].
Foot ulcers in people with diabetes have a serious impact on
health-related quality of life [9–11], and the cost of treatment
for diabetic foot ulceration to the National Health Service
(NHS) in Englandwas estimated at £837m to £962m in 2014–
2015 [12]. Economic impact is high in terms of personal costs
Correspondence to: Gill Norman. E-mail: gill.norman@manchester.ac.uk
This is an open access article under the terms of the Creative Commons
Attribution License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited.
ª 2020 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK 1
DIABETICMedicine
DOI: 10.1111/dme.14326
to patients and carers, including lost work time and produc-
tivity [13]. The long-term impact can be severe; up to 85% of
foot-related amputations are preceded by ulceration [14,15],
and people with diabetes have a 10–20-fold higher risk of non-
traumatic lower limb amputation than those without diabetes
[16,17]. Following amputation, risk of death in the next 5
years is high, >40% in one cohort study [18].
A meta-analysis of control groups from trials in which
participants with diabetic foot ulceration received good
wound care reported that 24% of ulcers healed completely
by 12 weeks and 31% by 20 weeks [19]; however, the risk
of re-ulceration can be up to 70% over 5 years [20–23].
Risk of ulceration and the time taken for an ulcer to heal
are probably influenced by many factors along causal
pathways with complex inter-relationships [24,25]. Adverse
psychosocial factors may affect pathophysiological processes
or impact on lifestyle factors such as smoking (thereby
affecting tissue perfusion) or may influence the effectiveness
of diabetes treatments and self-management behaviours,
eventually leading to poorer foot outcomes [26–31]. Psy-
chosocial interventions, which are intended to interrupt these
pathways, may therefore depend on multiple mechanisms for
any effects on ulcer development and healing. An interven-
tion that primarily addresses depression may indirectly
operate through an effect on foot care [32] and general
self-care behaviours, and physical activity [30,33], as well as
acting in a direct physiological way [30,34]. Direct and
indirect effects may not be independent and it is important to
consider the multicomponent nature of both treatments and
their potential effects.
The aim of the present review was to identify and
summarize the existing evidence for the effectiveness of
psychosocial interventions that seek to promote the healing,
and/or reduce the occurrence of, foot ulceration in people
with diabetes.
Methods
The full methods are reported in the protocol [35].
We included randomized controlled trials (RCTs) involv-
ing participants with type 1 or type 2 diabetes with or
without active foot ulceration if they assessed any individual
or group psychological, behavioural or social intervention
alone or in combination (e.g. cognitive behavioural therapy,
motivational interviewing, counselling, psychological ther-
apy, social support, mindfulness). We included cluster-
randomized trials (where groups of participants were ran-
domly allocated at the group level, e.g. attendees at a
particular clinic), but excluded quasi-randomized studies (i.e.
where allocation was based on a non-random method such as
alternation). We included studies of exercise or educational
interventions, provided the intervention was more than
printed materials and had a psychosocial component. We
considered any comparator to be eligible, including alterna-
tive interventions, usual care and no treatment.
Primary outcomes were complete healing and ulceration.
Secondary foot-related outcomes were rate of wound heal-
ing, amputation, standardized diabetic foot ulceration risk
assessments, foot-care knowledge or behaviours, and foot-
related adverse events. Studies had to report a foot-related
outcome to be included. We also assessed: mortality; non-
foot-ulcer-related adverse events; general and diabetes-re-
lated health behaviours and indicators; social activity/partic-
ipation; psychological outcomes (e.g. depression, anxiety and
stress); and health-related quality of life, reported using
validated scales or disease-specific questionnaires.
We searched the Cochrane Central Register of Controlled
Trials (CENTRAL); Ovid MEDLINE (from 1946); Ovid
EMBASE (from 1974) and PsycINFO (from 1967) without
restrictions in March 2019 (see Appendix S1). We searched
bibliographies of included studies, systematic reviews, guid-
ance or health technology assessments In addition, three
clinical trial registries were searched for ongoing and
completed studies (ClinicalTrials.gov, the WHO Interna-
tional Clinical Trials Registry and the EU Clinical Trials
Register).
Two researchers independently screened records at each
stage. Studies that were considered to be potentially eligible
on the basis of title and abstract were obtained as full papers;
studies which were clearly not an RCT, were not an
evaluation of a potentially relevant intervention or did not
include a diabetes population were not further evaluated.
One researcher extracted data and a second researcher
checked. Where necessary, we attempted to contact authors
or obtained translations. We assessed risk of bias using the
Cochrane tool [36,37], and completeness of intervention
reporting using the Template for Intervention Description
and Replication (TIDieR) checklist [38]. We performed
GRADE (Grading of Recommendations Assessment, Devel-
opment and Evaluation) assessment for each comparison and
outcome [39]; this classifies evidence as high, moderate, low
What’s new?
• Foot ulcers in people with diabetes are associated with
high levels of morbidity, and have been linked to
multiple psychosocial factors.
• Despite identifying 31 randomized controlled trials
(4511 participants) we found only low-quality evidence
for a range of psychosocial interventions; there were no
clear effects on ulceration or ulcer healing. Reporting of
key outcomes and intervention characteristics was
limited.
• Our review highlights the lack of reliable evidence to
inform clinical practice and the need for adequately
powered, rigorously designed studies to assess theoret-
ically informed psychosocial interventions for clinical
outcomes such as ulcer incidence, recurrence, healing
and ulcer-free time.
2
ª 2020 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK
DIABETICMedicine Psychosocial interventions for foot ulcers in people with diabetes  G. Norman et al.
or very low quality, which relates directly to the uncertainty
with which decision makers should regard evidence [40].
Studies were combined using narrative synthesis according
to intervention type and population targeted. Where clinically
appropriate, we pooled data in random-effects meta-analyses.
Where possible we reported or calculated hazard ratios (HRs)
[41–43] or risk ratios (RRs). For continuous outcomeswe used
mean differences. In each case we calculated 95% CIs.
Heterogeneity was assessed using I2 statistics and visual
inspection. We were unable to conduct a planned funnel plot
analysis because of an insufficient number of studies.
Results
We included 31 studies (35 records) that enrolled 4511
people [references S1–S31]. We also identified 11 ongoing
studies [S32–S42].
We screened 9832 records [2940 from database searches,
5408 identified for a companion review (Westby et al.,
submitted for publication, 2020) or prior scoping work, and
1485 from trial registers and references; Fig. 1]. A list of 127
excluded full-text studies is available on request.
Characteristics of studies
Twenty-four studies assessed interventions for preventing
ulceration (4451 participants) [S1–S3,S5,S7–S12,S14–S18,
S20–S22,S25–S27,S29–S31]. Seven studies assessed interven-
tions for treating ulceration in people with existing diabetic
foot ulcers (418 participants) [S4,S6,S13,S19,S23,S24,S28].
Sixteen studies had inclusion criteria which either specified
only an absence of risk factors or did not specify risk level
[S1,S2,S5,S8–S10,S12,S15–S18,S25,S26,S29–S31]. Four
studies enrolled only participants with previous ulceration
[S7,S11,S21,S27] and four enrolled both people with and
without prior ulceration [S3,S14,S20,S22].
Sample sizes ranged from 13 to 530 (Table S1). Two
studies were cluster-randomized trials [S29,S31]. Most par-
ticipants had type 2 diabetes (often 100%), and mean ages
ranged from 44 to 70 years. Overall 48% of participants
were male, but this proportion was higher in people with
current or prior ulceration. Studies were conducted across 15
high- and middle-income countries. Only one prevention
study enrolled outpatients [S17]; most treatment studies
enrolled inpatients [S4,S6,S19,S23,S28]. Most studies
enrolled participants who reflected the clinical population
from which they were drawn; exclusion criteria tended to be
restricted to ensuring the linguistic and cognitive ability to
understand the intervention.
Interventions were diverse but with some common
approaches. Many involved some element of foot care
education [S1–S5,S7,S8,S10–S12,S14–S18,S20,S22,S23,S25,
S26,S28–S30]. A strong educational focus was particularly a
feature of prevention studies. Psychological approaches were
References identified: main 




(companion review; scoping 
search =  5408)
References identified: 
additional searches (trial 
registers; reference checking) 
= 1485
Total number of records screened = 9832
Total number of records obtained at full text = 169
Number of included studies = 31
Prevention – low risk = 16
Prevention – high risk = 8
Treatment = 7
Number of ongoing studies = 11
Records clearly not 
relevant = 9663
Studies excluded with 
reasons = 127
FIGURE 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram for review of psychosocial interventions for
preventing or treating diabetic foot ulcer.
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more common in treatment studies [S6,S13,S19,S24]. All
interventions involved face-to-face sessions; some also used
telephone, postal or SMS contacts. Interventions were evenly
divided between small group and individual delivery. Inten-
sity and duration varied greatly, from single sessions to
multiple sessions over several years. Most were delivered by
healthcare practitioners, usually nurses. The most common
venue was an outpatient clinic (which would be normally
attended by the participants), followed by an inpatient clinic
or participants’ homes. Some studies had multiple compo-
nents, e.g. an initial group clinic session followed by home
visits. Follow-up ranged from 30 days to 10 years and was
longer in prevention studies. Most studies used comparators
of ’usual care’ or ’standard care’, while a minority assigned
participants to an alternative intervention. In many instances
the usual/standard care included some elements of the
intervention, typically in provision of education.
Many studies focused on behavioural, knowledge and
psychological outcomes. Only nine of 24 prevention studies
reported ulceration [S3,S7,S8,S10,S11,S14,S17,S21,S22] and
only two of seven treatment studies reported complete
healing [S6,S24]. Seven studies reported amputation [S8,
S10–S12,S14,S19,S22] and three reported mortality [S11,
S14,S22]. Outcome data are summarized in Tables S2 and
S3. We focus on studies that reported review primary
outcomes and studies that enrolled people with current or
prior ulceration.
Reporting and quality of evidence
The quality of methods and reporting were suboptimal in all
studies (Tables S4 and S5). Many studies had high risks of
important biases, in particular detection bias (unblinded
outcome assessment) and attrition bias (randomized partic-
ipants absent from analyses). All except two studies had
several unclear risks of bias, so we were uncertain about their
true risk of bias (Table S4). All effect estimates were
imprecise, with wide CIs based on low participant and event
numbers. All evidence was therefore of low or very low
quality [39]; we note where evidence is very low quality. We
were unable to use a funnel plot to assess the possibility of
publication bias because of the low number of studies in our
meta-analysis, however, we found no evidence of publication
bias more generally (since most of the studies we identified
were small and reported no treatment effect).
TiDIER assessment revealed severe limitations in inter-
vention descriptions in most studies (Table S5) [38]. Levels of
detail varied considerably; more recent studies demonstrated
better reporting. Many studies did not report a robust
theoretical basis for the intervention, although most gave a
brief rationale. Items relating to basic intervention descrip-
tions, that is, what was delivered, by whom and how often,
tended to be reported. However, there was particularly poor
reporting of professionals’ modifications and participants’
adherence, so we were very unsure about participants’
adherence to most interventions. Only five studies reported
information on adherence [S2,S5,S23,S29,S31]; only one
specifically assessed intervention fidelity [S29].
Prevention studies involving participants without prior foot
ulceration
Sixteen studies (3228 participants) enrolled unselected pop-
ulations or populations selected to exclude those with prior
ulceration; the incidence of other risk factors varied and was
often not reported [S1,S2,S5,S8–S10,S12,S15–S18,S25,S26,
S29–S31]. Most evaluated interventions with a strong
educational focus [S1,S2,S5,S10,S12,S15–S18,S25,S26,S29,
S30]. Interventions included an educational programme
specifically focused on self-efficacy [S29], skills and confi-
dence-building combined with education [S5], education
with behavioural contracts [S12], exercise and motivation
[S9], podiatric education, care and individualized counselling
[S8], and SMS support [S31]. Comparators included usual
care or lower intensity or standard education.
Only three of 16 studies reported ulceration [S8,S10,S17],
while two reported amputation [S8,S12]. No meta-analysis
was conducted because there was heterogeneity in both
interventions and populations. Whilst a range of behaviour
[S1,S5,S8,S10,S12,S16,S25,S26,S29,S31], knowledge [S8,
S10,S15–S18,S29, S31] and psychological outcomes [S5,
S17,S25,S29] was reported (Table S3), most measures in
most studies did not show clear differences between groups;
exceptions were some increases in knowledge or ’adherence’.
Several studies also reported measures of foot condition such
as problems requiring treatment or lesion scores [S1,S2,S8,
S9,S12,S15], while two reported quality of life [S5,S29].
Studies reporting ulceration are highlighted below.
Family involvement in intensive education vs standard care
One study (62 participants) compared intensive diabetes foot
education with ongoing family involvement, for 2 years, with
usual care. This programme was delivered by a diabetes
nurse-led multidisciplinary team and included classes every 3
to 6 months for patients and family members, recruitment of
family assistance in daily foot care routines, additional
workshops and skills exercises. There was no clear difference
in either new ulceration at 2-year follow-up (RR 0.06, 95%
CI 0.00 to 1.08) or in amputations (RR 0.19, 95% CI 0.01 to
3.87) [S10].
Specially adapted education for people with impaired
cognitive function vs standard education
One study (68 participants) involving people with impaired
cognition receiving insulin therapy found similar rates of new
ulceration at 6 months between inpatients receiving a
specially adapted education (DikoL) programme and those
receiving standard education (RR 1.06, 95% CI 0.29 to
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3.90). The DikoL programme used 15 instead of 20 teaching
hours and was less theoretical, with more time for practical
exercises. This was very-low-quality evidence [S17].
Podiatric-based programme compared with usual care
One study (530 participants) found no difference in new
ulceration at 7 years between those receiving a 1-year
intervention delivered by podiatrists, which involved indi-
vidualized counselling, education and exercise sessions on
foot care and as-needed podiatric treatment, and those
receiving written information only (RR 0.99, 95% CI 0.06 to
15.67) [S8]. There was also no clear difference in amputa-
tions (but only two events; RR 4.93, 95% CI 0.24 to 102.11)
[S8].
Prevention studies involving participants with prior foot
ulceration
Eight studies (865 participants) enrolled participants with
prior ulceration [S3,S7,S11,S14,S20–S22,S27]. Four included
only participants with prior ulceration S7,S11,S21,S27] and
four participants with and without prior ulceration [S3,S14,
S20,S22]. Six studies evaluated educational interventions (53
to 259 participants) [S3,S7,S11,S14,S20,S22]. Pilot studies
evaluated a modified cognitive behavioural therapy inter-
vention (15 participants) [S21] and motivational interview-
ing (13 participants) [S27]. Six studies reported ulceration
[S3,S7,S11,S14,S21,S22].
Educational intervention vs standard care
Five studies (572 participants) compared educational inter-
ventions with standard care [S3,S7,S11,S14,S20]. Four
reported new ulceration and were pooled in a random-
effects meta-analysis; in two (303 participants) [S7,S11], all
participants had prior ulceration and, in another two (173
participants) [S4,S14], a proportion had prior ulceration.
Studies were undertaken in specialist care outpatient settings
and delivered by nurses or researchers in small groups in
clinic or individually at participants’ homes, where this was
reported. Three used single face-to-face sessions, with tele-
phone follow-up in one case; one used four sessions with
additional follow-up [S3]. Interventions contained elements
such as: single-sex groups with active question-led partici-
pation to build confidence [S7]; interactive group sessions
with practical exercises [S14]; personalized risk factor
exploration and follow-up [S11]; focus groups with patient
involvement including specially designed games [S3]. Follow-
up ranged from 6 months to 2 years.
There was no clear effect of educational interventions on
new ulceration (RR 0.93, 95% CI 0.67 to 1.29; I2 = 17%);
there was no evidence of differential effects depending on
whether studies included only participants with prior ulcer-
ation.
Two studies reported amputation; one found an RR at 12
months of 0.98 (95% CI 0.41 to 2.34) [S11], another
reported no amputations at 6 months [S14]. Two studies
reported mortality; there were no clear differences between
groups at 6 months (RR 1.47, 95% CI 0.33 to 6.46; I2 = 0%)
[S7,S14]. There was very-low-quality evidence for various
psychological and behavioural outcomes. Two studies
reported incomplete data for behavioural outcomes: visiting
podiatrist and wearing prescribed shoes [S7] and ’adherence
to foot inspection’ and barefoot walking [S20]. Another
reported no between-group differences with regard to Dia-
betic Foot Scale (short form) and Hospital Anxiety and
Depression Scores (HADS) but higher intervention group
scores on the Nottingham Assessment of Functional Footcare
scale [S11].
Intensive education vs standard education
One study (259 participants) found that intensive education
delivered up to four times monthly, including foot-care
practices and quizzes, varying intensity with perceived risk,
appeared to reduce new ulceration over 10 years, compared
with standard education delivered monthly (RR 0.52, 95%
CI 0.34 to 0.81) [S22]. There were fewer amputations in the
intensive education group (RR 0.62, 95% CI 0.42 to 0.92)
but no clear difference in mortality (RR 0.63, 95% CI 0.37
to 1.08); this was very-low-quality evidence [S22].
Cognitive behavioural intervention vs standard care
A pilot study (15 participants) in people with prior ulceration
found no difference in ulceration between a specially adapted
group cognitive behavioural therapy-based intervention over
several months and standard care (one ulcer per group; RR
0.63, 95% CI 0.05 to 7.90); the study was not designed to
detect a difference [S21]. The study focused on social
support, illness cognition, mood and self-care behaviours.
The intervention group reported increased self-care beha-
viours and greater belief in treatment effectiveness.
Motivational interviewing vs standard care
A pilot study (13 participants) compared a brief motivational
interviewing intervention with standard care in people with
prior ulceration [S27]. Ulceration was not reported. There
was no sustained difference in an objective measure of
’recommended footwear adherence’ over 3 months.
Treatment studies involving participants with current
ulceration
We identified seven treatment studies (418 participants); in
five studies participants were inpatients for diabetic foot
ulcer treatment [S4,S6,S19,S23,S28], while two enrolled
outpatients [S13,S24]. All were underpowered to detect
ª 2020 The Authors.
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important clinical differences (30–100 participants) and
interventions varied considerably, although three were pri-
marily educational [S4,S23,S28]. Five studies reported some
wound healing measure, but only two reported complete
healing [S6,S24].
Continuous pharmacist support vs usual care
A study of continuous pharmacist support (data from 29
participants), incorporating three to four treatment-focused
counselling sessions, discharge conversations and 3-monthly
post-discharge follow-up meetings, information and plan-
ning support, found no difference in complete healing at 12
months compared with usual care (RR 1.03, 95% CI 0.65 to
1.61) [S6]. It is unclear whether pharmacist support reduced
new ulceration (RR 0.37, 95% CI 0.11 to 1.22). These
completed case analyses provided very-low-quality evidence.
Understanding well-being vs usual care
One study (60 participants) compared an ’understanding
well-being’ intervention (three discussion and reflection
sessions over 6 weeks combined with diary writing) to usual
care [S24]. Time to complete healing was measured over 6
weeks; the HR was reported not to show difference between
the groups (P value reported), but attrition and imprecision
were high. Other outcomes included self-efficacy, self-care
and quality of life. This was all very-low-quality evidence.
Foot-care education plus motivation and a topical platelet gel
vs platelet gel alone
One study (100 participants) compared education with a
motivational component (three sessions with a registered
nurse over 20 days) plus a medical intervention (platelet gel)
with the gel alone. Wound status, measured by the modified
Bates-Jensen wound assessment tool found no difference in
change scores at 30 days [S4].
Self-care capacity enhancement vs usual care
One study (60 participants) compared initial small group
training aimed at enhancing participants’ capacity for self-
care (twice-weekly follow-up home visits over 4 months) to
usual care [S28]. Aspects of healing status [categorical
descriptors of wound dimensions and healing phase (epithe-
lializing/granulating/inflammatory)] showed very-low-qual-
ity evidence of benefit to the intervention. There was also
improvement in self-care status.
Decision navigation vs usual care
A pilot study (30 participants) compared decision navigation
for diabetic foot ulcer care, involving an assistant psychol-
ogist using a semi-structured telephone interview to develop
personalized plans and accompanying participants to their
consultant appointment, to usual care [S13]. The focus was
psychological outcomes including: decisional self-efficacy
scale; ’adherence’; decision conflict; decision regret; and
health-related quality of life. Healing rate was reported as a P
value for change in ulcer size over 12 weeks, without
between-group comparisons. Adjusted analyses showed no
clear differences between groups except for decision conflict
(reduced in the intervention group).
Supportive psychotherapy vs usual care
One study (30 participants) compared between three and 11
weekly sessions of supportive inpatient psychotherapy with
usual care. There was no difference in amputations (RR 1.00,
95% CI 0.31 to 3.28) [S19]. This study primarily addressed
depression and reported reduced scores on the HADS and the
Problem Areas in Diabetes Scale in the intervention group
but increases in the control group, using baseline-adjusted
analyses.
Self-care and self-efficacy vs usual care
One study (60 participants) compared a weekly foot self-care
and self-efficacy group programme to usual care [S23]. No
review primary outcomes were assessed. There was very-low-
quality evidence of an intervention benefit on management
self-efficacy and foot self-care behaviour scales.
Discussion
Twenty-four of 31 studies in the present review examined
ulcer prevention rather than treatment of current ulcers. All
except one prevention study enrolled outpatients, whereas
five treatment studies involved inpatients, although most
people with diabetic foot ulcers are treated as outpatients.
Most participants were older people with type 2 diabetes.
Most participants in treatment studies and prevention studies
after prior ulceration were men. In these respects the
populations may be representative of clinical practice and it
was also noticeable that there were few exclusion criteria
based around comorbidities, which would limit the applica-
bility of the findings in practice. Both high- and low- to
middle-income countries were represented.
Most prevention interventions were primarily educational
in focus. Interventions were delivered face-to-face, individ-
ually, or to small groups, usually by healthcare professionals.
Treatments were most commonly delivered by nurses and
seldom by health or other psychologists; varying levels of
detail were given about the training provided to personnel.
This may mean that the interventions were delivered in a
more pragmatic, but less ideal way, but it was difficult to
determine the extent to which this was the case from the
published studies. The most common setting was an outpa-
tient clinic, although both inpatient clinics and home visits
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were included. These factors may also mean that many
interventions are easily compatible with normal clinical
practice. A wide range of approaches were taken to make
both educational and more psychologically focused inter-
ventions meaningful and effective; more recent studies often
focused on participant-driven concerns.
Despite the relatively large number of studies identified,
there was limited evidence for the impact of interventions
aimed at either prevention or treatment of foot ulcers:
ulceration and healing outcomes were often not reported
and, where reported, showed no clear effects and were
additionally affected by limitations in study size, design and
reporting. The extent to which the included studies may be
considered to have assessed the effectiveness of the interven-
tions in situations analogous to clinical practice varies. The
relatively unselected populations enrolled in the included
studies, the settings and personnel delivering most interven-
tions, and the fact that comparisons were with ’usual care’,
’standard care’ or an alternative intervention mean that most
of the existing studies are pragmatic in nature [44].
The study outcomes reported reflected the type of inter-
ventions assessed and the populations enrolled. As most
interventions were primarily educational, their objective,
especially in populations without prior ulceration, was often
changes in foot care behaviour, knowledge or beliefs. The
primary outcomes in the present review (incidence of new or
recurrent ulceration and complete healing of active ulcers)
were reported by a minority of studies. New or recurrent
ulceration was reported in only nine of 24 prevention trials
of which six enrolled participants with prior ulceration; one
treatment trial reported re-ulceration [S3,S6–S8,S10,S11,
S14, S17,S21,S22]. Complete wound healing (the outcome
that matters most to people living with ulcers) [45,46] was
reported by only two of seven treatment trials [S6,S24]; three
studies reported other measures of healing [S4,S13,S28].
Outcome reporting was often limited to P values, measures
of within-group change, or statements of statistical signifi-
cance. The outcomes assessed and measures reported varied
widely, this was particularly the case for psychological
outcomes. While there were reporting limitations associated
with the studies identified, we found no evidence of a pattern
of missingness in the studies identified that would indicate
publication bias. The fact that so many of the included
studies were both small and reported no intervention effect
supports the view that we have identified the majority of the
existing studies.
Most studies, including those which reported ulceration or
healing, were not well designed to assess these outcomes,
often having too few participants or insufficient follow-up.
The median (range) sample size was 60 (30–100) in treat-
ment studies and 103 (13–530) in prevention studies.This
meant that effect estimates were imprecise, especially where
incidence of ulceration was low. In most instances we could
not use meta-analysis to combine studies because the
interventions compared or the population enrolled were
too heterogenous. Assessment of risk of bias showed many
studies with multiple domains at high risk of bias and almost
all had several unclear risks of bias.
The combination of heterogeneity, imprecision and risk of
bias means that all the evidence in the review was of low or
very low quality. Many of the findings were therefore very
uncertain or were of low certainty but suggested that there
was no clear effect of the intervention, with CIs that included
the possibility of both benefit and harm, as well as no effect.
Where evidence is drawn from studies with methodological
issues and low numbers of participants it is difficult to
determine whether there is truly no effect of the interventions
assessed; further research is very likely to change the findings.
We are uncertain not only about the effects of interventions
but about whether these uncertain findings are reliable [39].
Application of the TiDIER checklist [38] demonstrated
that, although most studies reported a rationale for inter-
vention(s), this was only rarely embedded in a theoretical
basis for effectiveness. Only three (educational) studies in
people without prior ulceration reported such a theoretically
based rationale, none assessed ulceration [S25,S29,S30].
Studies in people with prior ulceration mostly did not report
clear rationales for how interventions might impact out-
comes, although most did report ulceration [S4,S6,S11,S14].
The exception was a pilot study of specially adapted
cognitive behavioural therapy, and this was not powered to
assess recurrent ulceration [S21]. Several treatment studies
assessed interventions with clear reasoning for their likely
efficacy in relation to the psychological and behavioural
outcomes, which were their primary focus [S13,S19,S23,S24,
S28]. However, only one study related the process to wound
healing [S24] and none were powered to assess this. Studies
providing clear intervention rationales were published rela-
tively recently.
Interventions were described in varying detail; a few
educational studies provided only minimal detail for us to
identify an eligible psychosocial component [S4,S14,S15,
S18,S22], a majority gave partial information and a minor-
ity (mostly psychological studies) provided full information
on all aspects of programmes [S11,S13,S19,S21,S25,S28,
S29]. Approximately half the interventions reported details
on tailoring for either some participants (e.g. ensuring
cultural appropriateness, provision in participants’ first
language, adaptation to medical needs, educational or
literacy capabilities) [S2,S3,S6,S7,S23,S29] or all partici-
pants (individualized and participant-driven approaches)
[S8,S13,S15,S19,S22,S26–S28]. In most cases fidelity of
intervention delivery and level of participant adherence
were unclear. Exceptions were four studies which reported
measures to improve or define adherence [S2,S5,S23,S31]
and one which implemented a detailed protocol to ensure
fidelity [S29].
In conclusion, during the period 2014–2015, £1 in every
£140 spent by the NHS in England was consumed by the
costs of managing the diabetic foot, and these costs are rising
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[12]. Observational evidence has continued to highlight
psychological and behavioural associations with ulcer out-
comes. Yet the focus in intervention studies has steadfastly
remained on educational interventions, as reflected in previ-
ous systematic reviews and most studies identified by the
present rigorous review.
We have identified a growing body of randomized evidence
which explores interventions aimed at supporting people
with diabetes in avoiding and managing ulceration. If we are
to realize improvements in foot ulcer outcomes for patients
and healthcare providers, as noted by the National Institute
for Health and Care Excellence [47], we need robust trial
evidence of psychosocial interventions with a clear theoret-
ical basis that examine effects on clinical outcomes. Such
trials should be appropriately powered with adequate follow-
up to assess effectiveness in preventing ulceration and,
ultimately, amputation. Where appropriate they should
follow guidance on the development and evaluation of
complex interventions [48].
Trials with high relevance to clinical practice may deliver
interventions using healthcare professionals routinely present
in clinic settings; there may be a balance to be struck between
expertise and transferability. As an example, one of our
identified studies used research nurses to deliver an interven-
tion after they had received training from a psychologist.
Trials in people with active ulceration should ideally assess
time to healing and re-ulceration. The limited reporting of
both methodology and key outcomes (new or recurrent
ulceration, complete healing and quality of life), and the wide
range of measures employed to capture outcomes such as
foot-care behaviours and knowledge and, especially, psycho-
logical health, underlines the need for future trials to refer to
the ongoing COMET initiative, which will provide a core
outcome set for management of foot ulceration in people
with diabetes [49]. Issues with methodology and reporting
highlight the need for adherence to good reporting practice
for RCTs [50].
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